Arabic PRO Measures for Head and Neck Cancer Radiotherapy.

Launched by KING SAUD UNIVERSITY · Oct 26, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on improving how we understand and measure the experiences of Arabic-speaking patients undergoing radiotherapy for head and neck cancer. The researchers want to validate specific surveys, known as patient-reported outcome measures (PROMs), to ensure they accurately capture the concerns and experiences of these patients. By doing this, healthcare providers can better identify the challenges faced by patients and evaluate how effective their treatments are.

To participate in the study, individuals must be at least 18 years old and currently receiving, or have previously received, radiotherapy for head and neck cancer at King Saud University Medical City. Participants will be asked to complete a series of surveys before, during, and after their treatment, which will help researchers gather important information on the patients' concerns and how they relate to their personal and medical backgrounds. This study is currently recruiting participants, and everyone, regardless of gender, is welcome to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 18 or above and who is planned for receiving and who is currently receiving and who had already received radiotherapy for the HNC at King Saud University Medical City.
• Exclusion Criteria:
• • Individuals who are less than 18 years, presence of debilitating disease (e.g. heart failure) or who lack the capacity to read, understand and sign the informed consent and those.